Modalis Therapeutics Corporation (TYO:4883)
Japan flag Japan · Delayed Price · Currency is JPY
33.00
+1.00 (3.13%)
Sep 16, 2026, 3:30 PM JST

Modalis Therapeutics Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,3404,7007,0793,9169,76917,753
Market Cap Growth
-45.73%-33.61%80.79%-59.92%-44.97%-71.84%
Enterprise Value
5951,6544,5922,0196,08812,290
Last Close Price
32.0056.00102.00124.00335.00613.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-15.1215.1215.1243.6817.75
PS Ratio
----244.2417752.87
PB Ratio
1.351.682.002.843.323.20
P/TBV Ratio
1.351.682.002.843.323.67

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----152.2112289.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.11--0.30--
Net Debt / Equity Ratio
-1.11-1.01-1.01-1.07-1.00-0.89
Net Debt / EBITDA Ratio
--2.680.621.514.25
Net Debt / FCF Ratio
1.441.332.500.641.405.78
Asset Turnover
----0.010
Quick Ratio
4.5820.9930.569.5120.8027.42
Current Ratio
4.6821.5830.929.8821.7128.15
Return on Equity (ROE)
-72.15%-67.91%-53.48%-110.75%-63.67%-12.55%
Return on Assets (ROA)
-40.69%-41.53%-29.24%-57.48%-28.04%-12.54%
Return on Invested Capital (ROIC)
-----666.56%-177.13%
Return on Capital Employed (ROCE)
-86.10%-78.10%-37.40%-129.70%-69.00%-21.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-61.11%-45.79%-18.60%-61.06%-27.66%-4.16%
FCF Yield
-57.01%-45.11%-20.23%-58.56%-21.41%-4.81%
Buyback Yield / Dilution
-32.19%-67.52%-48.96%-6.39%-1.23%-9.12%